Beginning January 5 (12:01 a. m. Eastern Standard Time), all passengers arriving from China, Hong Kong, and Macau, or who have been in the country within 10 days prior to departure to the United States, will be required to provide a negative PCR or monitored antigen check to board flights to the United States. In addition, the same requirement will apply to passengers who were physically provided in China in the 10 days prior to flight through Incheon International Airport in South Korea, Toronto Pearson International Airport and Vancouver International Airport.
Amid concerns about a lack of transparency around knowledge of COVID cases and the relaxation of COVID-related restrictions, China is facing its biggest coronavirus outbreak since the pandemic began. Acute cases could potentially infect more than 800 million people in the coming months. Such an increase in infections over a very short period of time increases the chances of a new variant emerging, and with the threat of new mutations comes the threat of higher rates of transmission and mortality.
In response, several countries, in addition to the United States, Japan, Italy, India, South Korea and Taiwan, are implementing measures for travelers, either to restrict the spread of infection and for the early detection of new variants. Effective January 5, 2023, for entry into the United States directly or indirectly from China, Hong Kong, and Macau, all passengers over the age of 2, regardless of nationality or vaccination status, will be required to provide evidence of a PCR or negative antigen. Test performed within two days at the boarding gate. The only exception will be for those who have recently tested positive. Those who have had COVID-19 in the 90 days leading up to their vacation in the United States may submit COVID-19 recovery documents in lieu of a negative verification result.
In addition to measures taken to protect those who test positive while traveling from China to the United States, CDC is also expanding its Traveler Genomic Surveillance (TGS) program to other airports. TGS, controlled through the Center for Travel Disease Control Health Directorate, checks foreign travelers for new variants entering the country and fills gaps in global surveillance. During the first few days of the Omicron surge, TGS detected two weeks of Omicron subvariants before they were reported elsewhere. As a component of the program, foreign travelers who arrive volunteer to take part and anonymously provide nasal swabs that are then sent for verification to enable variant detection and viral characterization to help provide data on a variant’s transmissibility, virulence, and reaction to existing remedies or vaccines.
As the case counts and variants evolve and increase, so do the rules for overseas and efforts to control the spread. Before making plans for a trip abroad, be sure to check the rules in place for each planned destination, be prepared for delays and interruptions. and constantly monitor reliable data resources for updates.
Listen to this article: Here
About this author
It is your duty to read, perceive and agree to the Terms of Use and Privacy Policy of the National Law Review (NLR) and National Law Forum LLC prior to the National Law Review website. National Law Review is a free, offline database of legal and business articles. The content and links on www. NatLawReview. com are intended for general data purposes only. Any legal analysis, legislative update or other content and link should not be construed as a legal or professional recommendation or a replacement for such recommendation. . No attorney-client or confidential relationship is formed through the transmission of data between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations that come with the content of the National Law Review online page. You need a legal or professional recommendation, contact a lawyer or other appropriate professional advisor.
Some states have moral laws and regulations related to the practices of solicitation and disclosure through attorneys and/or other professionals. National Law Review is not a law firm and www. NatLawReview. com is not intended to be a referral service for lawyers and/or other pros. The NLR is not willing and does not intend to solicit or refer an attorney or other professional. NLR does not answer legal questions and will not refer you to a lawyer or other professional if you ask us for such information.
Under certain state laws, the following statements may be required on this online page and we have included them to fully comply with those rules. Choosing a lawyer or other professional is a vital resolution and should not be based only on exposure notices from lawyers – past effects do not guarantee a similar outcome. Declaration in accordance with the Texas Rules of Business Conduct. attest to the accuracy of any mention of legal specialization or other professional designations.
The National Law Review – National Law Forum LLC 3 Grant Square #141 Hinsdale, IL 60521 Phone (708) 357-3317 or toll free (877) 357-3317. If you would like to contact us by email, please click here.